Provided by Tiger Trade Technology Pte. Ltd.

FOSUN PHARMA

17.150
+0.0100.06%
Volume:3.62M
Turnover:62.09M
Market Cap:45.48B
PE:11.54
High:17.290
Open:16.880
Low:16.880
Close:17.140
52wk High:27.920
52wk Low:14.505
Shares:2.65B
HK Float Shares:534.00M
Volume Ratio:0.67
T/O Rate:0.68%
Dividend:0.46
Dividend Rate:2.66%
EPS(LYR):1.486
ROE:6.95%
ROA:1.40%
PB:0.80
PE(LYR):11.54
PS:0.91

Loading ...

BRIEF-Shanghai Fosun Pharma Unit's Drug Registration Application For Flurbiprofen Axetil Injection Approved By NMPA

Reuters
·
Apr 10

FOSUN PHARMA's Flurbiprofen Axetil Injection Receives Marketing Authorization

Stock News
·
Apr 10

Shanghai Fosun Pharma - Unit's Drug Registration Application for Flurbiprofen Axetil Injection Approved by Nmpa

THOMSON REUTERS
·
Apr 10

Fosun Pharma Schedules 28 April Board Meeting to Review Q1 2026 Results

Bulletin Express
·
Apr 10

Fosun Pharmaceutical Names CFO

MT Newswires Live
·
Apr 03

Fosun Pharmaceutical's Subsidiary Gets Nod for Phase I Trial for Breast Cancer Drug

MT Newswires Live
·
Apr 02

FOSUN PHARMA Subsidiary Receives Clinical Trial Approval for HLX319 Drug

Stock News
·
Apr 01

Fosun Pharmaceutical to Set Up Parallel Fund Structure

MT Newswires Live
·
Apr 01

Fosun Pharma Unit Gets China Nod for Tumor Drug Trial

MT Newswires Live
·
Mar 31

Fosun Pharma Subsidiary Secures NMPA Approval to Launch Phase I Trial of FXB0871 for Advanced Solid Tumors

Bulletin Express
·
Mar 31

BRIEF-Shanghai Fosun Pharma Announces Approval From NMPA For Clinical Trial Of FXB0871

Reuters
·
Mar 31

Shanghai Fosun Pharma - Approval From Nmpa for Clinical Trial of Fxb0871

THOMSON REUTERS
·
Mar 31

FOSUN PHARMA Reports 2025 Results: Revenue Hits 41.7B Yuan with 21.7% Net Profit Growth

Deep News
·
Mar 25

FOSUN PHARMA Shares Surge Over 5% as Annual Net Profit Climbs 21.69% to 3.37 Billion Yuan

Deep News
·
Mar 25

Stock Track | Fosun Pharma Soars 5.21% Intraday on Strong 2025 Earnings and Dividend Announcement

Stock Track
·
Mar 25

FOSUN PHARMA Declares Final Dividend of HK$0.39 Per Share

Stock News
·
Mar 25

Fosun Pharma Announces RMB0.39 Final Dividend for FY2025

Bulletin Express
·
Mar 25

Fosun Pharma 2025 Results: Net Profit Up 21.69%, Innovative-Drug Sales Surge 29.59%

Bulletin Express
·
Mar 25

Shanghai Fosun Pharma - Proposed to Distribute Cash Dividend of RMB0.39 for Each Ordinary Share

THOMSON REUTERS
·
Mar 25

Press Release: Fosun Pharma Announces 2025 Annual Results

Dow Jones
·
Mar 24